Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitis

Neurourology and Urodynamics

Volumn 32, Issue 1, 2013, Pages 58-62

  Keller, Joseph ^a   Chiou, Hung Yi ^a   Lin, Herng Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

bladder cancer; IC BPS; interstitial cystitis

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CYSTALGIA; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 84871366106     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22283     Document Type: Article

References (30)

1. Parsons CL,. Interstitial cystitis: Epidemiology and clinical presentation. Clin Obstet Gynecol 2002; 45: 242-9. (Pubitemid 34212427)
2. Metts JF,. Interstitial cystitis: Urgency and frequency syndrome. Am Fam Physician 2001; 64: 1199-206.
3. Driscoll A, Teichman JMH,. How do patients with interstitial cystitis present? J Urol 2001; 166: 2118-20. (Pubitemid 33065233)
4. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society. Am J Obstet Gynecol 2002; 187: 116-26.
5. Rosenberg MT, Newman DK, Page SA,. Interstitial cystitis/painful bladder syndrome: Symptom recognition is key to early identification, treatment. Cleve Clin J Med 2007; 74: S54-62.
6. Messing EM, Stamey TA,. Interstitial cystitis: Early diagnosis, pathology, and treatment. Urology 1978; 12: 381-92. (Pubitemid 9056165)
7. Leppilahti M, Tammela TLJ, Huhtala H, et al. Prevalence of symptoms related to interstitial cystitis in women: A population based study in Finland. J Urol 2002; 168: 139-43. (Pubitemid 34640800)
8. Rosenberg MT, Hazzard M,. Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office. J Urol 2005; 174: 2231-4. (Pubitemid 41611784)
9. Rosenberg MT, Hazzard MA,. Prevalence of interstitial cystitis in a primary care setting. Urology 2007; 69: 48-52.
10. Parsons CL,. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 2011; 107: 370-5.
11. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7. (Pubitemid 36019639)
12. Ohshima H, Tatemichi M, Sawa T,. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003; 417: 3-11. (Pubitemid 36960042)
13. Burin GJ, Gibb HJ, Hill RN,. Human bladder cancer: Evidence for a potential irritation-induced mechanism. Food Chem Toxicol 1995; 33: 785-95.
14. Johansson SL, Cohen SM,. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13: 291-8. (Pubitemid 27332851)
15. American Cancer Society. Cancer facts & figures 2006. USA: American Cancer Society; 2006.
16. Michaud DS,. Chronic inflammation and bladder cancer. Urol Oncol 2007; 25: 260-8. (Pubitemid 46670749)
17. Cheng CL, Kao YH, Lin SJ, et al. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Safety 2011; 20: 236-42.
18. Kang JH, Chen YH, Lin HC,. Comorbidity profiles among patients with ankylosing spondylitis: A nationwide population-based study. Ann Rheum Dis 2010; 69: 1165-8.
19. Tissot WD, Diokno AC, Peters KM,. A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004; 172: 478-80. (Pubitemid 38900182)
20. Németh D,. Bladder cancer arising from interstitial cystitis. Z Urol Nephrol 1980; 73: 741-5. (Pubitemid 11165086)
21. Lokeshwar VB, Selzer MG, Cerwinka WH, et al. Urinary uronate and sulfated glycosaminoglycan levels: Markers for interstitial cystitis severity. J Urol 2005; 174: 344-9. (Pubitemid 40825755)
22. Erickson DR, Xie SX, Bhavanandan VP, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol 2002; 167: 2461-9. (Pubitemid 34533146)
23. Ruggieri MRSr,. Mechanisms of disease: Role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 2006; 3: 206-15.
24. Sun Y, Chai TC,. Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 2006; 290: C27-34.
25. Erickson DR, Kunselman AR, Bentley CM, et al. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol 2004; 172: 2256-60. (Pubitemid 39507503)
26. Hussain SP, Hofseth LJ, Harris CC,. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-85. (Pubitemid 37328863)
27. Yamamoto M, Wu HH, Momose H, et al. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res 1992; 52: 5329-33.
28. Uchida K, Samma S, Rinsho K, et al. Stimulation of epithelial hyperplasia in rat urinary bladder by Escherichia coli cystitis J Urol 1989; 142: 1122-6. (Pubitemid 19250785)
29. Kawai K, Yamamoto M, Kameyama S, et al. Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation Cancer Res 1993; 53: 5172-5. (Pubitemid 23333383)
30. Kawai K, Kawamata H, Kemeyama S, et al. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus Cancer Res 1994; 54: 2630-2. (Pubitemid 24173749)